Description:
EHLERS-DANLOS SYNDROME, TYPE III
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of Connective Tissue, Muscle, and Bone |
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Race
|
White
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
3 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase,Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Remarks |
Clinically affected; EDS, hypermobility type based on clinical evaluation; small hard lumps under skin at trauma sites; hypermobilty; smooth skin with atypical scarring; frequent joint dislocation and pain since childhood; collagen analysis performed on a skin biopsy was normal ruling out most of the vascular and some forms of the arthrochalasia and dermatosparaxis types of EDS; slow healing; easy bruising; arthritis and joint pain; striae on abdomen; thinning of scarring; increased extensibility at elbows; arthritic changes and decreased movement in fingers; ruptured discs; myopia and a stigmatism; decrease in kyphosis at the neck and increased lordosis in lower back; mother with history of mixed connective tissue disorder disorder; same donor as GM19481 Lymphoblast |
Passage Frozen |
3 |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
10% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|